切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2009, Vol. 03 ›› Issue (02) : 210 -214. doi: 10.3877/cma.j.issn.1674-0807.2009.02.012

综述

维生素D受体与乳腺癌的关系
郑维1   
  1. 1.410005 长沙,湖南省人民医院乳甲外科
  • 收稿日期:2008-11-24 出版日期:2009-04-01

Correlation of vitamin Dreceptor with breast cance

Wei Zheng   

  • Received:2008-11-24 Published:2009-04-01
引用本文:

郑维. 维生素D受体与乳腺癌的关系[J/OL]. 中华乳腺病杂志(电子版), 2009, 03(02): 210-214.

Wei Zheng. Correlation of vitamin Dreceptor with breast cance[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2009, 03(02): 210-214.

[1]
Norman A W.Minireview:vitamin D receptor:new assignments for an already busy receptor.Endocrinology,2006,147:5542-5548.
[2]
Zinser G,Packman K,Welsh J.Vitamin D3 receptor ablation alters mammary gland morphogenesis.Development,2002,129:3067-3076.
[3]
Albrechtsson E,Jonsson T ,Moller S,et al.Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number.Pancreatology,2003,3:41-46.
[4]
Mezzetti G,Barbiroli B,Oka T.1,25-dihydroxycholecalciferol receptor regulation in hormonally induced differentiation of mouse mammary gland in culture.Endocrinology,1987,120:2488-2493.
[5]
Colston KW,Berger U,Wilson P,et al.Mammary gland 1,25-dihydroxyvitamin D3 receptor content during pregnancy and lactation.Mol Cell Endocrinol,1988,60:15-22.
[6]
Welsh J,Wietzke J A,Zinser G M,et al.Vitamin D3 receptor as a target for breast cancer prevention.J Nutr,2003,133:2425S-2433S.
[7]
van den Bemd G J,Pols H A,van Leeuwen J P.Anti-tumor effects of 1,25-dihydroxyvitamin D3 and vitamin D analogs.Curr Pharm Des,2000,6:717-732.
[8]
van den Bemd G J,Chang G T.Vitamin D and vitamin D analogs cancer treatment.Curr Drug Targets,2002,3:85-94.
[9]
SwamiS,Krishnan A V,Feldman D.1,25-dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.Clin Cancer Res,2000,6:3371-3379.
[10]
耿翠芝,吴祥德.与乳腺癌发病风险相关的基因多态性研究进展.中华乳腺病杂志:电子版,2007,1:202-205.
[11]
柳晓义,胡建霞,王宇,等.TNFR II基因-196M/R 多态性与乳腺癌易感性的相关性.中华乳腺病杂志:电子版,2008,2:165-167.
[12]
Ingles S A,Ross R K,Yu M C,et al.Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.J Natl Cancer Inst,1997,89:166-170.
[13]
Zmuda J M,Cauley J A,Ferrell R E.Molecular epidemiology of vitamin D receptor gene variants.Epidemiol Rev,2000,22:203-217.
[14]
Sweeney C,Curtin K,Murtaugh M A,et al.Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers.Cancer Epidemiol Biomarkers Prev,2006,15:744-749.
[15]
McCullough M L,Stevens V L,Diver W R,et al.Vitamin D pathway gene polymorphisms,diet,and risk of postmenopausal breast cancer:a nested case-control study.Breast Cancer Res,2007,9:R9.
[16]
Ingles S A,Garcia D G,Wang W,et al.Vitamin D receptor genotype and breast cancer in Latinas(United States).Cancer Causes Control,2000,11:25-30.
[17]
Curran J E,Vaughan T,Lea R A,et al.Association of a vitamin D receptor polymorphism with sporadic breast cancer development.Int J Cancer,1999,83:723-726.
[18]
Guy M,Lowe L C,Bretherton Watt D,et al.Vitamin D receptor gene polymorphisms and breast cancer risk.Clin Cancer Res,2004,10:5472-5481.
[19]
Abbas S,Nieters A,Linseisen J,et al.Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk.Breast Cancer Res,2008,10:R31.
[20]
Chen W Y,Bertone Johnson E R,Hunter D J,et al.Associations between polymorphisms in the vitamin D receptor and breast cancer risk.Cancer Epidemiol Biomarkers Prev,2005,14:2335-2339.
[21]
Buyru N,Tezol A,Yosunkaya Fenerci E,et al.Vitamin D receptor gene polymorphisms in breast cancer.Exp Mol Med,2003,35:550-555.
[22]
Dunning A M,McBride S,Gregory J,et al.No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer.Carcinogenesis,1999,20:2131-2135.
[23]
SillanpääP,Hirvonen A,Kataja V,et al.Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk.Pharmacogenetics,2004,14:239-245.
[24]
崔静,沈坤炜,沈镇宙,等.维生素D 受体基因多态性与乳腺癌的相关性.中华医学遗传学杂志,2001,18:286-288.
[25]
Hou M F,Tien Y C,Lin G T,et al.Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients.Breast Cancer Res Treat,2002,74:1-7.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[10] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要